TTW Proprietary Technology | Improving Patient Safety. The first 15 minutes of a consultation could be the most expensive in the healthcare process. Diagnosis – and, more importantly, misdiagnosis – matters. Body Interact™, an immersive medical training environment, enhances high-level skills in diagnosis, reduces medical errors and improves efficiency in healthcare delivery. www.bodyinteract.com
Crioestaminal | Stem Cells Education. This movie was designed to support a multi-channel strategy combining stereo projection in 3D theatres and workshops and on websites. When creating this project, TTW needed to develop a powerful visual language, combining the emotion of fetal development with a dynamic narrative about the benefits of the cryo-preservation of stem cells. www.crioestaminal.pt
Genomatix | Dynamic Product Detailing. "When contracting TTW I was a bit worried about how they would fare with the unknown topic (...). However, I was very pleased that the people at TTW were very committed and they compensated such potential disadvantages by extra efforts on their side. I do not think that we lost anything due to the fact that we are in Germany and they in Portugal. We are satisfied with the result and we would do it again." Thomas Werner, CEO of Genomatix
TTW Proprietary Technology | Cardiovascular Risk Simulation. We have created this application to support clinical decision-making, while including suggestions for the appropriate treatment for each patient profile. Also, the technology includes a module to empower individuals with regard to their current health risks, encouraging improved compliance with medical instructions.
Novartis | Pharmacological Mechanism of Action. This film is generally considered to be the first European science-based film made in stereo 3D animation. The movie supported a large number of workshops with GPs. This stereo 3D film describes the causes of hypertension, and proceeds to cover the RAAS system, the sympathetic nervous system, the role of the kidneys, and the control of arterial hypertension by means of a new drug.
TTW Proprietary Technology | Getting patients involved in their own care: the next frontier in health care value. Our eHealth platform Vita Salutis™ unlocks the power of a person-centered healthcare system that is: enabled by data; powered by people; sustained by feedback loops. Vita Salutis™ is being used in Patient Support Programs for risk reduction or chronic disease management and Hospital Readmission Reduction Programs. www.vitasalutis.com
TTW Proprietary Technology | Diabetes Education. This application combines the classic forms of scientific communication with a new media-learning approach, allowing Life Sciences students and professionals to gain a deeper understanding of diabetes. This project combines high quality CG animations with smart content organization, offering a rich and meaningful way to discover the disease, ranging from clinical issues to molecular mechanisms.
TTW Proprietary Technology | Basic Life Support Education. A cardiopulmonary arrest can happen to anyone, anywhere. Everyone should know how to act quickly. This app created by TTW includes short videos which train the user in the Basic Life Support manoeuvres and which help find the nearest emergency hospitals.
Novartis | Pharmacological Mechanism of action. This 3D movie was created to highlight the fact that people with diabetes can frequently develop microvascular and macrovascular complications. It also explains the intelligent mechanisms that reduce glucose fluctuations and the benefit of minimizing the risk of complications for the patient.